Comments on: Why the availability bias is killing innovation in pharma marketing

By: Steve

Steve — Fri, 28 May 2010 22:39:44 +0000

I agree with David. If we want to speed adoption, we need to share and work together. Collaboration as the Catalyst! It seems to be working with some of our partners in this space…and I am open to more! Be not afraid.

By: DJ Edgerton

DJ Edgerton — Tue, 16 Feb 2010 19:50:00 +0000

By: David Ormesher

David Ormesher — Mon, 15 Feb 2010 22:16:45 +0000

Your tips on changing the culture are right on. If life ultimately is reversion to the mean, then we need to move the mean.

Another helpful concept here is Moore’s crossing the chasm. Moving innovation from early adopters to the early majority requires that we recognize that the pragmatists don’t engage until they see their peers adopting. Ultimately that’s what changes the risk profile; if other Big Pharma are doing it, then somebody must have already done the legal due diligence and I won’t get fired.

This suggests that we do a better job of sharing successes with each other so we develop a portfolio of examples of “people like us” that are innovating.

By: David Reim

David Reim — Fri, 12 Feb 2010 22:06:14 +0000

I call Pharma a “slow follower” industry. Therefore, selling into requires a whole different mindset.

By: Brad at Pharma

Brad at Pharma — Fri, 12 Feb 2010 17:42:08 +0000

Bee-frackin-rilliant.

This is something I think we hit in almost everything. Not just in Social Media. But I constantly hear from my colleagues in the Social Media space that this is one of the major roadblocks to… oh, I don’t know… everything we’re all trying to do in our various companies with regards to Social Media. The paucity of Social Media programs is a testament to that, I’m not talking out of school here. Thanks for the Jedi Mind Trick, I’ll give it a shot

FULL TRANSPARENCY: The opinions expressed here represent mine and mine alone, and do not in any way, shape, or form represent those of my employer. #iwork@novartis